These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 1957722)

  • 21. [Therapy of cancer of the prostate in stage C].
    Escudero Barrilero A
    Arch Esp Urol; 1989; 42 Suppl 2():155-63. PubMed ID: 2700881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Natural history of cancer of the prostate].
    Guiter J
    J Urol (Paris); 1987; 93(8):469-74. PubMed ID: 3326898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are monotherapy options reasonable for T3 prostate cancer?
    Schellhammer PF; Lynch DF
    Semin Urol Oncol; 1997 Nov; 15(4):207-14. PubMed ID: 9421447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
    Tsihlias J; Kapusta LR; DeBoer G; Morava-Protzner I; Zbieranowski I; Bhattacharya N; Catzavelos GC; Klotz LH; Slingerland JM
    Cancer Res; 1998 Feb; 58(3):542-8. PubMed ID: 9458103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome for lymph node-positive prostate cancer.
    Swanson GP; Riggs MW; Herman M
    Prostate Cancer Prostatic Dis; 2008; 11(2):198-202. PubMed ID: 17519924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Update of experience with prostatic cancer].
    Nitecki S; Kuten A; Cohen Y
    Harefuah; 1993 Mar; 124(5):261-5, 320, 319. PubMed ID: 8495915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cancer of the prostate with predominant lymphatic manifestation. Apropos of 2 cases].
    Herer B; Waligora J; Delfraissy JF; Dormont J
    J Urol (Paris); 1987; 93(8):475-7. PubMed ID: 3440840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical analysis of 683 prostatic cancer patients in the Tokai Urological Cancer Registry].
    Obata JK; Kuriyama M; Fujita K; Sakai S; Okishio N; Sakagami H; Higashino I; Miyake K
    Hinyokika Kiyo; 1996 Jul; 42(7):503-7. PubMed ID: 8809558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.
    Ghavamian R; Bergstralh EJ; Blute ML; Slezak J; Zincke H
    J Urol; 1999 Apr; 161(4):1223-7; discussion 1227-8. PubMed ID: 10081874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study of prostatic cancer--statistical analysis of 184 cases in the latest 21 years].
    Yamashita A; Hayashi N; Sugimura Y; Yanagawa M; Arima K; Nakano S; Kimbara H; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1995 Jun; 41(6):447-53. PubMed ID: 7645452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of tegafur administration combined with hormonal therapy in patients with newly diagnosed stage D prostatic cancer].
    Kobayashi N; Yoshida K; Takahashi T; Saitoh H; Tari K; Satake I; Kojima S; Tsujii T; Negishi T; Horiuchi S
    Hinyokika Kiyo; 1990 Jul; 36(7):793-800. PubMed ID: 2239576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies of progressive factors of stage A prostatic cancer].
    Suzuki T; Shimizu T; Imai K; Yamanaka H; Suzuki K; Takahashi H
    Hinyokika Kiyo; 1989 Feb; 35(2):259-63. PubMed ID: 2735237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
    Zincke H
    Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
    [No Abstract]   [Full Text] [Related]  

  • 35. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
    Cadeddu JA; Partin AW; Epstein JI; Walsh PC
    Urology; 1997 Aug; 50(2):251-5. PubMed ID: 9255297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.
    D'Amico A
    BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What is the best strategy of hormonal therapy in the treatment of locally advanced prostate cancer?].
    Ehara H; Nakano M; Deguchi T
    Hinyokika Kiyo; 2006 Jun; 52(6):473-7. PubMed ID: 16848361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognosis in stage a prostate cancer].
    Murase T; Kuriyama M; Maeda S; Ando Y; Itoh H; Watanabe H
    Hinyokika Kiyo; 1996 Sep; 42(9):639-43. PubMed ID: 8918661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic significance of clinical stage including extent of disease (EOD) in prostate cancer].
    Fujinami K; Kondo I; Miura T; Harada M; Uemura H; Hosaka M; Kawasaki C
    Hinyokika Kiyo; 1998 Apr; 44(4):259-63. PubMed ID: 9617622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.